JP Stock MarketDetailed Quotes

4506 Sumitomo Pharma

Watchlist
  • 609
  • -2-0.33%
20min DelayMarket Closed Nov 22 15:30 JST
242.32BMarket Cap-768P/E (Static)

Sumitomo Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sumitomo Pharma H1 FY2025 Earnings Date

Currency：JPYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
181.59B
180.75B
-838.50M
Miss Est.
+18.96%
+18.41%
-0.98%
EPS
-9.00
-81.12
-72.12
Miss Est.
+94.72%
+52.43%
-401.97%
Analyst Rating
Underperform

Nov 8, 2024

Sumitomo Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 80.517B--
Jan 31, 20252025/Q3-- / 90.067B--
Oct 30, 20242025/Q290.074B / 85.908B--
Jul 31, 20242025/Q190.675B / 82.622B--
May 14, 20242024/Q479.530B / 79.948B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 80.517B--
Jan 31, 20252025/Q3-- / 90.067B--
Oct 30, 20242025/Q290.074B / 85.908B--
Jul 31, 20242025/Q190.675B / 82.622B--
May 14, 20242024/Q479.530B / 79.948B--

Unlock Free Earnings Estimates

Sumitomo Pharma Earnings Reports

  • Sumitomo Pharma: Confirmation letter

    Oct 31 22:30 ET

  • Sumitomo Pharma: Semi-Annual Report - 205th Term (2024/04/01 - 2025/03/31)

    Oct 31 22:26 ET

  • Sumitomo Pharma: Interim report

    Oct 30 02:42 ET

  • Sumitomo Pharma: 2024 (fiscal year ending 2025/3) 2nd quarter financial results (IFRS) supplementary materials

    Oct 30 00:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Underper form

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      62.50%

    • Underperform

      0.00%

    • Sell

      37.50%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data